Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status.
about
Using activation status of signaling pathways as mechanism-based biomarkers to predict drug sensitivityNext-generation medicine: combining BCR-ABL and Hedgehog-targeted therapies.New insight into hedgehog signaling in hematological malignancies.PTCH1 expression at diagnosis predicts imatinib failure in chronic myeloid leukaemia patients in chronic phase.
P2860
Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Tracking molecular relapse of ...... ing Hedgehog signaling status.
@en
Tracking molecular relapse of ...... ing Hedgehog signaling status.
@nl
type
label
Tracking molecular relapse of ...... ing Hedgehog signaling status.
@en
Tracking molecular relapse of ...... ing Hedgehog signaling status.
@nl
prefLabel
Tracking molecular relapse of ...... ing Hedgehog signaling status.
@en
Tracking molecular relapse of ...... ing Hedgehog signaling status.
@nl
P2093
P2860
P1433
P1476
Tracking molecular relapse of ...... ing Hedgehog signaling status.
@en
P2093
Alberto Ballestrero
Alessio Nencioni
Angelo Michele Carella
Anna Garuti
Antonia Cagnetta
Claudia Palermo
Daniele Reverberi
Franco Patrone
Gabriella Cirmena
Ilaria Rocco
P2860
P304
P356
10.3109/10428194.2012.708752
P577
2012-09-05T00:00:00Z